Regional Citrate Anticoagulation for Continuous Venovenous Hemodiafiltration Using Calcium-Containing Dialysate

American Journal of Kidney Diseases

Volumn 43, Issue 1, 2004, Pages 67-73

  Gupta, Monika ^a   Wadhwa, Nand K ^a,b   Bukovsky, Rose ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Anticoagulant Citrate Dextrose Formula A (ACD A); Calcium containing dialysate; Citrate anticoagulation; Continuous venovenous hemodiafiltration (CVVHDF)

Indexed keywords

ANTICOAGULANT AGENT; ANTICOAGULANT CITRATE DEXTROSE FORMULA A; CALCIUM CHLORIDE; CALCIUM ION; CITRIC ACID; HEPARIN; HYDROCHLORIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CALCIUM CONTAINING DIALYSATE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; DIALYSATE; FEMALE; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE; METABOLIC ALKALOSIS; PERITONEAL DIALYSIS; SIDE EFFECT; TECHNIQUE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

EID: 0346728945     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.09.014     Document Type: Article

References (25)

1. Kramer P, Wigger W, Rieger J, et al: Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55:1121-1122, 1977
2. Lauer A, Saccaggi A, Ronco C, et al: Continuous arteriovenous hemofiltration in the critically ill patient: Clinical use and operational characteristics. Ann Intem Med 99:455-460, 1983
3. Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration. A report of six months' experience. Ann Intem Med 100:358-367, 1984
4. Schneider NS, Geronemus RP: Continuous arteriovenous hemodialysis. Kidney Int Suppl 33:S159-S162, 1988
5. Barzilay E, Weksler N, Kessler D, et al: The use of continuous arteriovenous hemodialysis in the management of patients with oliguria associated with multiple organ failure. Intensive Care Med 14:444-445, 1988
6. Bellomo R, Boyce N: Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 39:M794-M797, 1993
7. Abramson S, Niles JL: Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8:701-707, 1999
8. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981, 1990
9. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 43:S237-S244, 1993
10. Paganini EP: Slow continuous hemofiltration and slow continuous ultrafiltration. ASAIO Trans 34:63-66, 1988
11. Kaplan AA, Petrillo R: Regional heparinization for continuous arterio-venous hemofiltration (CAVH). ASAIO Trans 33:312-315, 1987
12. Jeffrey RF, Khan AA, Douglas JT, et al: Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit. Artif Organs 17:717-720, 1993
13. Langenecker SA, Felfernig M, Werba A, et al: Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 22:1774-1781, 1994
14. Canaud B, Mion C, Arujo A, et al: Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration. Nephron 48:206-212, 1988
15. Davenport A, Will EJ, Davison AM: Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 66:431-437, 1994
16. Ohtake Y, Hirasawa H, Sugai T, et al: Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration Contrib Nephrol 93:215-217, 1991
17. Kutsogiannis DJ, Mayers I, Chin WD, et al: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802-811, 2000
18. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
19. Tolwani AJ, Campbell RC, Schenk MB, et al: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370-374, 2001
20. Bunchman TE, Maxvold NJ, Barnett J, et al: Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150-154, 2002
21. Morita Y, Johnson RW, Dorn RE, et al: Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242:32-42, 1961
22. Chadha V, Garg U, Warady BA, et al: Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819-824, 2002
23. Gabutti L, Marone C, Colucci G, et al: Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge. Intensive Care Med 28:1419-1425, 2002
24. Mehta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 93:210-214, 1991
25. Flanigan MJ, Pillsbury L, Sadewasser G, et al: Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 27:519-524, 1996